Photo Rounds

Growing scalp nodule

Author and Disclosure Information

 

References

Diagnosis: Cherry hemangioma

A benign hemangioma was suspected; however, given its unusually large size and uncharacteristic location, other entities such as amelanotic melanoma and lobular capillary hemangioma (pyogenic granuloma) needed to be ruled out. Pathology following a shave excision (with electrocautery) confirmed that this was a cherry hemangioma.

Consider biopsy to rule out malignancies in large scalp lesions.

Cherry hemangiomas, also known as senile hemangiomas or Campbell de Morgan spots, are a nearly ubiquitous benign vascular proliferation that increase in frequency and number with age.1,2 They also have been associated with pregnancy and some chemical exposures.3,4 In general, they are of no clinical consequence. Typically, they are 1- to 5-mm bright pink or bright to dark red papules located on the arms and trunk, a description that has persisted since at least 1947.1 Scalp involvement is considered rare.5

Differential includes malignant entities

The large size of the lesion in addition to its unusual location on the scalp prompted consideration of a malignant entity despite many features of a benign process.

Amelanotic melanomas classically are described as flesh-colored, but up to 70% of amelanotic melanomas may actually be red. Red amelanotic melanomas may account for nearly 4% of all melanomas and frequently are underrecognized.6 Pathology ruled out melanoma for this patient.

Lobular capillary hemangiomas (also known as pyogenic granulomas) typically manifest as rapidly growing, painless, friable papules or nodules in young adults and adolescents. Cutaneous lobular capillary hemangiomas are most often located on the head and neck, nose, face, extremities, and upper trunk. These benign lesions may grow to several centimeters in diameter and are prone to bleeding and ulceration, which this patient notably did not have.7

Continue to: Treatment often isn't required

Recommended Reading

Rapid-onset rash
MDedge Family Medicine
Biologic approved for atopic dermatitis in children
MDedge Family Medicine
Hyperkalemia most common adverse event in women taking spironolactone
MDedge Family Medicine
COVID-19 complicates prescribing for children with inflammatory skin disease
MDedge Family Medicine
California wildfires caused uptick in clinic visits for atopic dermatitis, itch
MDedge Family Medicine
Cancer risk elevated in hidradenitis suppurativa patients
MDedge Family Medicine
Atopic dermatitis in adults, children linked to neuropsychiatric disorders
MDedge Family Medicine
Today’s top news highlights: COVID-19 could worsen gambling problems, food allergies less common than thought
MDedge Family Medicine
Painful ear lesion
MDedge Family Medicine
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseases
MDedge Family Medicine